000 01685 a2200505 4500
005 20250514071742.0
264 0 _c20031014
008 200310s 0 0 eng d
022 _a1078-1439
024 7 _a10.1016/s1078-1439(02)00236-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLee, Cheryl T
245 0 0 _aConventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors.
_h[electronic resource]
260 _bUrologic oncology
_c
300 _a179-84 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aCarcinoma, Renal Cell
_xgenetics
650 0 4 _aCohort Studies
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aGenes, bcl-2
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xbiosynthesis
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNephrectomy
650 0 4 _aPrognosis
650 0 4 _aProto-Oncogene Proteins c-bcl-2
_xbiosynthesis
650 0 4 _aRetrospective Studies
650 0 4 _aSurvival Analysis
700 1 _aGenega, Elizabeth M
700 1 _aHutchinson, Brian
700 1 _aFearn, Paul A
700 1 _aKattan, Michael W
700 1 _aRusso, Paul
700 1 _aReuter, Victor E
773 0 _tUrologic oncology
_gvol. 21
_gno. 3
_gp. 179-84
856 4 0 _uhttps://doi.org/10.1016/s1078-1439(02)00236-3
_zAvailable from publisher's website
999 _c12594205
_d12594205